Guardian Pharmacy Services Inc

Earnings data Q3 2024

Earnings data Q4 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Guardian Pharmacy Services, Inc. engages in the provision of client service and resident care to long-term care communities. It offers assisted living and skilled nursing, group homes, behavioral health and organizations that serve individuals with intellectual and developmental disabilities. The company was founded by Fred Burke, David Morris, and Kendall Forbes on July 21, 2003 and is headquartered in Atlanta, GA.

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (“Guardian”) (NYSE: GRDN), one of the nation's largest long-term care (LTC) pharmacy services companies, today announced financial results for the third quarter ended September 30, 2024. Third Quarter 2024 Highlights Three Months Ended September 30, 2024 Revenue of $314.4 million, an increase of 20% year-over-year, driven by organic growth of the business and the previously announced acquisition of Heartland Pharmacy completed on April.

Guardian Pharmacy Services, Inc. Reports Third Quarter 2024 Financial Results

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation's largest long-term care (LTC) pharmacy services companies, today announced that they will participate in the Stephens Annual Investment Conference, being held in Nashville, on Thursday, November 21, 2024, including a fireside chat at 9:00am CT. The live audio webcast of the fireside chat will be available online at https://investors.guardianpharmacy.com. A replay of the fireside chat will also be availab.

Guardian Pharmacy Services, Inc. to Participate in Upcoming Investor Conference

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN), one of the nation's largest long-term care (LTC) pharmacy services companies, today announced that it will release its third quarter 2024 results on Tuesday, November 12, 2024, after market close and host a conference call to review the results at 4:30pm ET. Conference Call Details The conference call will be available via audio webcast at https://investors.guardianpharmacy.com and can also be accessed by dialing (800) 245.

Guardian Pharmacy Services, Inc. to Report Third Quarter 2024 Financial Results and Host Conference Call

Truist Securities has initiated coverage on Guardian Pharmacy Services, Inc GRDN, which operates long-term care pharmacies that facilitate the full lifecycle of pharmacy administration and associated consultative services for residents of long-term healthcare facilities (LTCFs).

Newly Listed Guardian Pharmacy Is Well Positioned In Highly Fragmented Market, Analyst Initiates With Buy Rating

GE Vernova LLC

BKV Corp

ESCO Technologies

Sarepta Therapeutics

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

This GE Vernova Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

BioAge Labs Inc

BingEx Ltd

FrontView REIT Inc

Premium Catering Holdings Ltd

SAG Holdings Ltd

Standardaero Inc

Three IPOs each raised at least $100 million this week, in a welcome bump in activity. Four IPOs and two SPACs submitted initial filings this past week. Six IPOs are currently scheduled to list in the week ahead.

U.S. IPO Weekly Recap: 3 Sizable Deals Trade Up

Guardian Pharmacy's shares rise 3.3% in their NYSE debut, giving the healthcare firm a market valuation of about $880 million.

Guardian Pharmacy shares rise 3% in lukewarm NYSE debut

Guardian Pharmacy, which provides pharmacy services to long-term healthcare facilities, raised $112 million in its U.S. initial public offering on Wednesday.

Healthcare firm Guardian Pharmacy raises $112 mln in US IPO

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (“Guardian”) today announced the pricing of its upsized initial public offering of 8,000,000 shares of Class A common stock at a public offering price of $14.00 per share. In addition, Guardian has granted the underwriters a 30-day option to purchase up to 1,200,000 additional shares of Class A common stock at the public offering price, less the underwriting discount. The shares are expected to begin trading on the New York Stock Exchan.

Guardian Pharmacy Services, Inc. Announces Pricing of Upsized Initial Public Offering

Global Engine Group Holding Ltd

Kairos Pharma Ltd

Legacy Education Inc

VanEck

Two small IPOs and two SPACs debuted this past week - Global Engine, Kairos Pharma, YHN Acquisition I, and Cayson Acquisition, respectively. Seven IPOs and three SPACs submitted initial filings. Eight companies are expected to price their IPOs in the upcoming week, including three larger deals.

U.S. IPO Weekly Recap: 2 Microcaps List As Pipeline Gets A Big Boost

Guardian Pharmacy Services has filed proposed terms for a $101 million U.S. IPO. The company focuses on providing outsourced pharmacy services to long-term healthcare facilities, targeting assisted living, skilled nursing, and behavioral health facilities. Guardian's financial performance has declined somewhat, with increased liabilities and a slowing growth rate.

Guardian Pharmacy Services' IPO Valuation Looks Pricey

Guardian Pharmacy Services said on Monday it was targeting a valuation as much as $973.5 million in its initial public offering in the United States.

Guardian Pharmacy targets up to $974 mln valuation in US IPO

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (“Guardian”) today announced the launch of its underwritten initial public offering of 6,750,000 shares of its Class A common stock pursuant to a registration statement filed with the U.S. Securities and Exchange Commission (the “SEC”). Guardian expects to grant the underwriters in the offering a 30-day overallotment option to purchase up to an additional 1,012,500 shares of Class A common stock at the initial public offering price, les.

Guardian Pharmacy Services Announces Launch of Initial Public Offering

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services announces a major seven state expansion in the western U.S. through a partnership with Heartland Pharmacy.

Guardian Pharmacy Services Expands Western Footprint Across Seven States Through Heartland Pharmacy Partnership

Guardian Pharmacy Services, Inc. has filed for a $115 million IPO of its Class A common stock, although the final figure may differ. The company provides pharmacy services to patients in assisted living, behavioral health, and long-term healthcare facilities. Guardian has shown steady revenue and profit growth in recent years and operates 43 pharmacies serving 156,000 patients in 28 states.

Guardian Pharmacy Services Launches U.S. IPO Effort

News for Guardian Pharmacy Services Inc Stock (GRDN)